A new globally leading centre for infectious diseases research, education and public health will be built in Melbourne to support the AIID. Providing state-of-the-art research platforms and technology will enable research translation into faster, more effective diagnostic tests, treatments, vaccines, and public health interventions for infectious diseases.
The Victorian Government has committed up to $400 million for the $650 million project, with funding also being provided by the University of Melbourne, the Doherty Institute and Burnet Institute, along with philanthropic support.
The new facility will be built in the world-leading Melbourne Biomedical Precinct. It will enable the Doherty Institute to expand and the Burnet Institute to relocate to the Parkville site. The facility will house more than 1000 scientists, academics, students and public health experts from the institutes alongside industry start-ups. Co-location will strengthen collaboration and engagement with their peers nationally and internationally and create a platform for new partnerships to be forged with the private sector and industry stakeholders.
The AIID will provide vital facilities and research platforms needed to develop vaccines and treatments for infectious diseases, including: